CD19 and systemic lupus erythematosus: Patients with severe flares had less prominent early decreases in CD19+CD20−CD138+ long-lived plasma cells (−23.5% versus −39.4%; p = 0.028) and CD19+CD27brightCD38bright SLE-associated plasma cells (−19.0% versus −27.8%; p = 0.045) [15].